Ticker,Title,Link
ONCT,"ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q2 2024",8/9/2024 12:59:01 AM
ONCT,Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results,8/8/2024 10:01:00 PM
ONCT,Oncternal Therapeutics Q2 2024 Earnings Preview,8/7/2024 9:35:44 PM
ONCT,Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2024 Financial Results,8/1/2024 10:05:00 PM
ONCT,Oncternal Therapeutics’ Positive Clinical Progress and Future Catalysts Underpin Buy Rating,7/16/2024 10:23:13 AM
ONCT,Oncternal Announces Enrollment Completed and Dosing Initiated for Sixth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer,7/15/2024 2:00:00 PM
ONCT,Oncternal Therapeutics to Present in JonesTrading Healthcare Summit,7/11/2024 10:05:00 PM
ONCT,"Analysts Offer Insights on Healthcare Companies: Springworks Therapeutics (SWTX), Cyclo Therapeutics (CYTH) and Oncternal Therapeutics (ONCT)",5/31/2024 10:30:21 AM
ONCT,Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer,5/30/2024 10:05:00 PM
ONCT,Oncternal Therapeutics: A Buy Rating on Strong Financials and Promising Catalysts,5/13/2024 10:16:49 AM
ONCT,"ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q1 2024",5/10/2024 12:58:03 AM
ONCT,Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results,5/9/2024 10:01:00 PM
ONCT,Notable earnings after Thursday's close,5/8/2024 9:35:55 PM
ONCT,Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results,5/2/2024 10:05:00 PM
ONCT,Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4),5/1/2024 3:00:00 PM
ONCT,Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer,4/18/2024 3:00:00 PM
ONCT,Oppenheimer Reaffirms Their Hold Rating on Oncternal Therapeutics (ONCT),4/17/2024 11:45:25 AM
ONCT,Buy Rating Affirmed for Oncternal Therapeutics with Adjusted Price Target Amid Positive Financials and Upcoming Catalysts,4/15/2024 10:17:04 AM
ONCT,Insiders Buying Westlake Chemical Partners And 2 Other Stocks,4/2/2024 3:06:24 PM
ONCT,Oncternal Participating in Virtual Fireside Chat with Key Opinion Leader on Treatment Landscape & New Treatment Options for Prostate Cancer,3/15/2024 2:00:00 PM
ONCT,"Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Xtant Medical Holdings (XTNT) and Oncternal Therapeutics (ONCT)",3/8/2024 1:50:37 PM
ONCT,Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results,3/7/2024 10:01:00 PM
ONCT,Notable earnings after Thursday's close,3/6/2024 10:35:33 PM
ONCT,Oncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results,2/29/2024 10:05:00 PM
ONCT,Oppenheimer Remains a Hold on Oncternal Therapeutics (ONCT),2/13/2024 12:37:18 PM
ONCT,Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference,2/6/2024 10:30:00 PM
ONCT,Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4),2/1/2024 3:00:00 PM
ONCT,American Airlines To Rally Around 32%? Here Are 10 Top Analyst Forecasts For Monday,1/29/2024 1:34:22 PM
ONCT,Top 5 Health Care Stocks That May Crash This Month,1/22/2024 1:34:46 PM
